Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 7.342M
December 31, 2025 6.463M
September 30, 2025 -1.259M
June 30, 2025 -1.682M
March 31, 2025 -0.489M
December 31, 2024 2.834M
September 30, 2024 7.694M
June 30, 2024 6.199M
March 31, 2024 5.806M
December 31, 2023 4.067M
September 30, 2023 2.962M
June 30, 2023 5.462M
March 31, 2023 -0.444M
December 31, 2022 -2.569M
September 30, 2022 -0.656M
June 30, 2022 -0.847M
March 31, 2022 5.157M
December 31, 2021 1.056M
September 30, 2021 1.511M
June 30, 2021 -2.078M
March 31, 2021 -0.156M
December 31, 2020 3.472M
September 30, 2020 3.149M
June 30, 2020 4.945M
March 31, 2020 2.539M
Date Value
December 31, 2019 4.376M
September 30, 2019 3.598M
June 30, 2019 3.326M
March 31, 2019 4.392M
December 31, 2018 3.322M
September 30, 2018 2.671M
June 30, 2018 3.096M
March 31, 2018 3.104M
December 31, 2017 3.757M
September 30, 2017 4.041M
June 30, 2017 3.235M
March 31, 2017 1.781M
December 31, 2016 -0.09M
September 30, 2016 -0.286M
June 30, 2016 -1.178M
March 31, 2016 -1.376M
December 31, 2015 -1.366M
September 30, 2015 -1.935M
June 30, 2015 -0.775M
March 31, 2015 -0.424M
December 31, 2014 0.58M
September 30, 2014 0.706M
June 30, 2014 -0.329M
March 31, 2014 -0.333M
December 31, 2013 -1.126M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M
Baxter International, Inc. 1.319B